CONTEXT: Serotonin [5-hydroxytryptamine (5-HT)] is an important local regulator of lactation homeostasis; however, the roles for the serotonin reuptake transporter and monoamine oxidase have not been known. OBJECTIVE: The aim of the study was to determine whether drugs that impact 5-HT affect human lactation physiology. DESIGN AND SETTING: We conducted laboratory studies of human and animal models and an observational study of the onset of copious milk secretion in postpartum women at a university medical center. PARTICIPANTS: We studied women expecting their first live-born infant; exclusion criteria were: referred to the medical center for another medical condition, known contraindication to breastfeed, and less than 19 yr of age and unable to obtain parental consent. INTERVENTION(S): The mothers were interviewed. The cell and animal studies consisted of a variety of biochemical, pharmacological, and genetic interventions. MAIN OUTCOME MEASURE(S): The human subjects outcome was prevalence of delayed onset of copious milk secretion. The cell and animal outcomes were physiological and morphological. RESULTS: Inhibiting serotonin reuptake in mammary epithelial cells altered barrier function, and the effects were amplified by coadministering a monoamine oxidase inhibitor. Direct delivery of fluoxetine by slow-release pellets caused localized involution. TPH1 knockout mice displayed precocious secretory activation. Among a cohort of 431 women, those taking SSRI were more likely (P = 0.02) to experience delayed secretory activation. CONCLUSIONS: Medications that perturb serotonin balance dysregulate lactation, and the effects are consistent with those predicted by the physiological effects of intramammary 5-HT bioactivity. Mothers taking serotonergic drugs may need additional support to achieve their breastfeeding goals.
CONTEXT: Serotonin [5-hydroxytryptamine (5-HT)] is an important local regulator of lactation homeostasis; however, the roles for the serotonin reuptake transporter and monoamine oxidase have not been known. OBJECTIVE: The aim of the study was to determine whether drugs that impact 5-HT affect human lactation physiology. DESIGN AND SETTING: We conducted laboratory studies of human and animal models and an observational study of the onset of copious milk secretion in postpartum women at a university medical center. PARTICIPANTS: We studied women expecting their first live-born infant; exclusion criteria were: referred to the medical center for another medical condition, known contraindication to breastfeed, and less than 19 yr of age and unable to obtain parental consent. INTERVENTION(S): The mothers were interviewed. The cell and animal studies consisted of a variety of biochemical, pharmacological, and genetic interventions. MAIN OUTCOME MEASURE(S): The human subjects outcome was prevalence of delayed onset of copious milk secretion. The cell and animal outcomes were physiological and morphological. RESULTS: Inhibiting serotonin reuptake in mammary epithelial cells altered barrier function, and the effects were amplified by coadministering a monoamine oxidase inhibitor. Direct delivery of fluoxetine by slow-release pellets caused localized involution. TPH1 knockout mice displayed precocious secretory activation. Among a cohort of 431 women, those taking SSRI were more likely (P = 0.02) to experience delayed secretory activation. CONCLUSIONS: Medications that perturb serotonin balance dysregulate lactation, and the effects are consistent with those predicted by the physiological effects of intramammary 5-HT bioactivity. Mothers taking serotonergic drugs may need additional support to achieve their breastfeeding goals.
Authors: Erica P Gunderson; Cora E Lewis; Gina S Wei; Rachel A Whitmer; Charles P Quesenberry; Steve Sidney Journal: Obstet Gynecol Date: 2007-03 Impact factor: 7.661
Authors: Carol Louik; Angela E Lin; Martha M Werler; Sonia Hernández-Díaz; Allen A Mitchell Journal: N Engl J Med Date: 2007-06-28 Impact factor: 91.245
Authors: Laurie A Nommsen-Rivers; Ann M Mastergeorge; Robin L Hansen; Arlene S Cullum; Kathryn G Dewey Journal: J Obstet Gynecol Neonatal Nurs Date: 2009 Mar-Apr
Authors: Emily Pinheiro; Debra L Bogen; Denada Hoxha; Jody D Ciolino; Katherine L Wisner Journal: Arch Womens Ment Health Date: 2015-01-15 Impact factor: 3.633
Authors: Luke E Grzeskowiak; Catherine Leggett; Lynn Costi; Claire T Roberts; Lisa H Amir Journal: Br J Clin Pharmacol Date: 2018-04-14 Impact factor: 4.335
Authors: A Schraenen; K Lemaire; G de Faudeur; N Hendrickx; M Granvik; L Van Lommel; J Mallet; G Vodjdani; P Gilon; N Binart; P in't Veld; F Schuit Journal: Diabetologia Date: 2010-10-07 Impact factor: 10.122
Authors: W J Zang; H Li; Z F Zhang; R QuZhen; Y Z CuoMu; D K Zhang; J Luo; J J Loor; H L Zheng Journal: J Anim Sci Date: 2018-04-03 Impact factor: 3.159